Takeover battle pushes Allergan to cut R&D jobs
Monday, July 28, 2014 - 06:30
in Paleontology & Archaeology
Besieged by serially acquisitive Valeant, the Botox maker will lay off 1500 staff to propel earnings growth
Besieged by serially acquisitive Valeant, the Botox maker will lay off 1500 staff to propel earnings growth